1. Volume 146, Issue 3, Pages 736-743.e1 (March 2014)
Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection 
Edward J. Gane, Catherine A. Stedman, Robert H. Hyland, Xiao Ding, Evguenia Svarovskaia, G. Mani Subramanian, William T. Symonds, John G. McHutchison, Phillip S. Pang 
Gastroenterology 
Volume 146, Issue 3, Pages e1 (March 2014)
DOI: /j.gastro
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1 HCV RNA levels during the first 8 weeks of treatment.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2014 AGA Institute Terms and Conditions

3. Figure 2
The figure shows mean hemoglobin during treatment among prior null responders receiving SOF/LDVFDC or SOF/LDVFDC plus RBV.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2014 AGA Institute Terms and Conditions

4. Supplementary Figure 1 Patient disposition.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2014 AGA Institute Terms and Conditions